In 2025, medical device manufacturers are grappling with heightened regulatory uncertainty, leading to slower reviews and communication difficulties with the FDA. This situation drives them to reassess operations for compliance and risk management, with a strong emphasis on maintaining product quality, which is vital for patient safety.
Why it Pays to Prioritize Quality Amid Regulatory Uncertainty
Related Posts
The IMTS 2024 Conference Sessions Announced
IMTS 2024 – The International Manufacturing Technology Show, has announced the full schedule for The IMTS 2024 Conference,…
Compatibility Testing – An Integral Part of Digital Transformation
Content 1. A brief on Compatibility Testing 2. Applicability of Compatibility Testing in the digital era 3. Advantages…
My Favorite of the Seven Basic Quality Tools
This month, I’m honored to speak at the ASQ Columbus (Ohio) Section’s annual conference on the theme “What…